Rx-to-OTC Switch

Browse Rx-to-OTC Switch Content

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Jul 20, 2022

CHPA’s President and CEO, Scott Melville, today released a statement in response to news of HRA Pharma’s application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the United States.

Jul 11, 2022

Industry executives from Europe and beyond gathered June 7-8, in Madrid, Spain, for the annual meeting of the Association of the European Self-Care Industry (AESGP), its first annual meeting since 2019. Under the theme “supporting innovation in self-care during times of uncertainty,” speakers focused on the European context of environmental sustainability, trends shaping the future of the consumer healthcare business, and the outlook for changes to the EU’s pharmaceutical framework, among other topics.

Jun 9, 2022

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Jan 26, 2022

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Oct 13, 2021

RSQ showcased the increased conversation around Rx-to-OTC switch among regulators, industry experts, and other stakeholders.

Sep 20, 2021

Janet Woodcock, Cara Welch, other consumer healthcare leaders to discuss emerging trends in OTCs, dietary supplements, and consumer medical devices

Aug 12, 2021

Just prior to the 4th of July holiday, the House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Appropriations Subcommittee released its FY 2022 Report.

Jul 7, 2021

Filter Results